F&G Annuities & Life’s first quarter was met with a negative market reaction, as non-GAAP earnings per share fell well below Wall Street expectations despite robust top-line growth. Management attributed the quarter’s results to strong asset growth, operational cost discipline, and the continued diversification of its business model. CEO Christopher Owsley Blunt highlighted the company’s ability to “flex across our products and channels to source the most attractive liabilities in the current environment,” while also noting the impact of lower alternative investment income and certain one-time items on profitability.
Is now the time to buy FG? Find out in our full research report (it’s free for active Edge members).
F&G Annuities & Life (FG) Q1 CY2026 Highlights:
- Revenue: $1.19 billion (30.7% year-on-year growth)
- Adjusted EPS: $0.82 vs analyst expectations of $1.01 (18.6% miss)
- Market Capitalization: $3.71 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From F&G Annuities & Life’s Q1 Earnings Call
- Raymond James asked whether current quarter EPS sets an intermediate-term baseline for growth; CFO Conor Ernan Murphy clarified that while core spread and expense improvements are sustainable, alternative investment returns are a key variable for earnings.
- Raymond James inquired about asset allocation opportunities amid changing credit spreads; CEO Christopher Owsley Blunt highlighted selective investments in mortgages and asset-backed lending, while stressing a conservative approach given tight spreads.
- Raymond James questioned surrender charge trends and policyholder behavior; Blunt and Murphy described surrender patterns as seasonally consistent and not a source of surprise this quarter.
- Truist Securities probed the impact of alternative investment performance on product pricing and ROE; Blunt explained that product repricing is dynamic and modeled for multiple scenarios, with capital assumptions set conservatively.
- Barclays explored the strategic review of Peak Altitude and its potential to generate capital for deployment; Murphy confirmed that proceeds could be used for debt reduction or other capital allocation priorities, while Blunt emphasized retaining strong distribution relationships regardless of the outcome.
Catalysts in Upcoming Quarters
In the coming quarters, our analysts will closely watch (1) execution on the shift toward fee-based, capital-light business lines, (2) management’s progress in extracting value from Peak Altitude through strategic alternatives, and (3) the impact of ongoing cost reductions on operating margins and return metrics. Additionally, trends in annuity and life insurance sales linked to demographic shifts will be crucial for assessing sustainable growth.
F&G Annuities & Life currently trades at $28.01, down from $29.47 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
